According to the latest report by Emergen Research, the Global Human Microbiome Market is expected to be worth USD 1,689.5 million by 2027 growing at a CAGR of 21.8%. Due to the growing awareness of human microbiome therapy, the human microbiome market is expected to develop significantly. Increased favourable regulations on probiotics and prebiotics by regulatory bodies are also expected to fuel the market. In addition, the increasing prevalence of chronic diseases is expected over the forecast timeframe to further propel market growth.
The growing prevalence of lifestyle-related diseases is a major driver of the human microbiome market globally, as therapeutic approaches can provide an efficient way to tackle serious health problems such as obesity, autoimmune disorders, and vulnerability to antibiotics, genetic disorders, metabolic diseases, cancer, Crohn’s disease, and bowel disorder.
Market growth is projected to be impeded by a lack of population awareness of probiotics and prebiotics and by insufficient research activities into microbiomes.
Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample-form/279
Key Highlights From The Report
- 4D Pharma PLC officially announced in January 2020 the start of a study investigating MRx0518 in patients with pancreatic cancer combined with radiation therapy, which is expected to improve 4D Pharma’s expertise in research and development activities for cancer treatment.
- The therapeutics sub-segment will hold the major market share over the projected period due to the increasing incidence of gastrointestinal conditions and the negative effects related to drugs.
- The infectious diseases sub-segment is estimated to hold the largest market over the forecast period. The awareness of the harmful impacts of the application of antibiotics on natural flora has shown the need for successful bacterial-targeted therapy for infectious diseases.
- North America is expected to lead the market during the projected timeframe because of the increase in the number of clinical trials and the rapid adoption of new technologies.
- Key participants include Synlogic, Inc., Seres Therapeutics, Vedanta Biosciences, Inc., MicroBiome Therapeutics, LLC, Evelo Biosciences, Symbiotix Biotherapies, Inc., 4D Pharma PLC, MetaboGen AB, Osel Inc, and Second Genome Inc. among others.
Check Our Prices@ https://www.emergenresearch.com/select-license/279
Emergen Research has segmented the global human microbiome market on the basis of product, type, technology, application, disease, and region:
Product Outlook (Revenue, USD Million; 2017-2027)
- Medical Foods
- Diagnostic Tests
Type Outlook (Revenue, USD Million; 2017-2027)
- Microbiome Drugs
- Fecal Microbiota Transplantation
Technology Outlook (Revenue, USD Million; 2017-2027)
Application Outlook (Revenue, USD Million; 2017-2027)
Disease Outlook (Revenue, USD Million; 2017-2027)
- Inflammatory Diseases
- Infectious Diseases
- Metabolic Disorders
- Cardiovascular Disease
- Irritable Bowel Syndrome
- Neurological Disorders
- Hematological Disorders
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/human-microbiome-market
Regional Outlook (Revenue, USD Million; 2017-2027)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- Rest of MEA
Take a Look at our Related Reports:
Topical Drug Delivery Market By Product Form (Semi-Solid, Solid Formulations, Transdermal Products, and Liquid Formulations), By Route (Dermal, Ophthalmic, Nasal, Others), By End-Use (Hospitals, Home Healthcare, Clinics, Diagnostic Centers, Burn Center), and By Regions
Medical Smart Textiles Market By Technology (Textile Sensors, Wearable Technology), By Application (Surgery, Bio-Monitoring, Therapy, and Wellness), By End-use (Hospitals and Clinics, Medical Academic and Research Center), and By Region
Operating Room Management Solutions Market By Solution Type (Data management and communication solutions, Operating room supply management solutions, Anesthesia information management solutions, Operating room scheduling solutions, Performance management solutions), By Mode of Deployment (Ob-premises, Cloud-based), By End-Use (Hospitals, Ambulatory surgical centers), and By Region
Patient Registry Software Market By Delivery, By Database, By Registry Type, By Function, By Software Type (Integrated, Standalone), By End-use (Government & Third-Party Administrators, Pharmaceutical Companies, Hospitals, Research Centers, Others), and By Region, Forecast to 2027
Ambulatory EHR Market By Deployment (Cloud-based, On-premises), By Practice Size (Solo Practices, Large Practices, Small-medium-sized Practices), By Application, By End-use (Independent Centers, Hospital-owned Ambulatory Centers, Others), and By Region, Forecasts to 2027
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
Read Full Press Release: https://www.emergenresearch.com/press-release/global-human-microbiome-market